Connecticut’s total cannabis retail revenue in 2025 is likely to be lower than in 2024 — despite growth in recreational sales — due primarily to a steep decline in medical cannabis sales.
📊 Key Trends
Recreational sales are up:
Recreational cannabis sales have increased year-over-year, with retailers selling around $197.4 million in 2025 (through November).
Medical sales have plunged:
Medical cannabis revenue is down by about $27 million compared with 2024. If December 2025 doesn’t hit record monthly sales, the combined total for 2025 will trail 2024’s overall cannabis sales.
🧠 Why Medical Sales Are Dropping
Fewer registered medical patients:
The number of registered medical cannabis patients in Connecticut has declined significantly over recent years, leaving a smaller base of buyers.
Shift to other markets/products:
Many former medical patients aren’t switching to the state’s recreational market. Instead, some are:
Traveling out of state (especially Massachusetts or New York) for higher-potency products.
Purchasing unregulated hemp or cannabis products—including vapes and flower—sold online or in non-licensed shops that offer more potency or convenience.
🧪 Medical vs. Recreational Product Differences
Medical patients previously had access to stronger concentrates and specialized edibles that are not always permitted in the recreational market. As the medical patient base shrank, manufacturers reduced or discontinued these products because they were no longer economically viable.
🏭 Industry Impact
Business closures:
Some dispensaries and manufacturers have closed due to market contraction.
Licensing bottlenecks:
The state has issued dozens of cultivation licenses, but many growers have not yet opened, slowing supply growth and product diversity.
🧠 Takeaway
Connecticut’s cannabis market is in a transitional phase. Recreational sales continue to grow, but not fast enough to fully offset the decline in medical cannabis revenue, leaving total 2025 sales on pace to fall below 2024. Competition from neighboring states and unregulated products remains a significant pressure on the legal market.
Dabbin-Dad Newsroom
CT’s Cannabis Boom Is Quietly Turning Into a Squeeze
If you liked this post, say thanks by sharing it
